Company · CIK 0001434316 · SIC 2836 — Biological Products, (No Diagnostic Substances) · Nasdaq
FATE THERAPEUTICS INC · FATE
Insider activity reported against this company. All insider holders · On EDGAR ↗
Reported at this company — common stock
| Trade | Reported (ET) | Insider | Shares | Avg price | Total | Owned after | Δ stake | Flags |
|---|---|---|---|---|---|---|---|---|
| Aug 4, 2026 SForm 4 → | Aug 5, 4:03 pm EDT | Cindy TahlSee Remarks | 38,800 | $2.46 | $95,405 | 589,355 | −6.18% | |
| Aug 4, 2026 SForm 4 → | Aug 5, 4:01 pm EDT | Bahram ValamehrPresident and CEO, Director | 43,947 | $2.46 | $108,101 | 591,815 | −6.91% |
Reported at this company — derivatives (options, RSUs, warrants)
No reported derivative activity in this period.